Dullei Min

2.8k total citations
18 papers, 591 citations indexed

About

Dullei Min is a scholar working on Immunology, Epidemiology and Transplantation. According to data from OpenAlex, Dullei Min has authored 18 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Epidemiology and 4 papers in Transplantation. Recurrent topics in Dullei Min's work include Immunotherapy and Immune Responses (5 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Dullei Min is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Dullei Min collaborates with scholars based in United States, Switzerland and South Korea. Dullei Min's co-authors include Kenneth I. Weinberg, Bruce R. Blazar, Angela Panoskaltsis‐Mortari, Georg A. Holländer, Makoto Kuro‐o, Brile Chung, Patricia A. Taylor, Dimitry M. Danilenko, Catherine L. Farrell and David L. Lacey and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

Dullei Min

16 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dullei Min United States 9 305 191 113 107 71 18 591
Kazuhiro Mochizuki Japan 15 286 0.9× 198 1.0× 179 1.6× 153 1.4× 53 0.7× 47 640
Limin Xing China 13 268 0.9× 331 1.7× 140 1.2× 104 1.0× 65 0.9× 103 631
Indira Sahdev United States 12 145 0.5× 190 1.0× 64 0.6× 87 0.8× 119 1.7× 25 547
Motoko Koyama United States 8 269 0.9× 291 1.5× 115 1.0× 99 0.9× 29 0.4× 13 491
Kazutoshi Aoyama Japan 9 304 1.0× 254 1.3× 106 0.9× 135 1.3× 32 0.5× 28 527
Mohammed S. Chaudhry United Kingdom 10 369 1.2× 193 1.0× 101 0.9× 256 2.4× 37 0.5× 17 614
Maria Giuseppina Cefalo Italy 14 80 0.3× 133 0.7× 76 0.7× 85 0.8× 52 0.7× 43 407
Jens Chemnitz Germany 9 219 0.7× 222 1.2× 54 0.5× 162 1.5× 36 0.5× 20 527
Rong‐Long Chen Taiwan 16 289 0.9× 413 2.2× 134 1.2× 348 3.3× 92 1.3× 56 920
Mohamed R. Daha Netherlands 8 466 1.5× 70 0.4× 109 1.0× 42 0.4× 35 0.5× 10 633

Countries citing papers authored by Dullei Min

Since Specialization
Citations

This map shows the geographic impact of Dullei Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dullei Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dullei Min more than expected).

Fields of papers citing papers by Dullei Min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dullei Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dullei Min. The network helps show where Dullei Min may publish in the future.

Co-authorship network of co-authors of Dullei Min

This figure shows the co-authorship network connecting the top 25 collaborators of Dullei Min. A scholar is included among the top collaborators of Dullei Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dullei Min. Dullei Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Bloch, Orin, Dullei Min, Tzu‐yin Lin, & Yuanpei Li. (2024). EXTH-80. A NOVEL BISAMINOQUINOLINE DERIVATIVE NANOPARTICLE (BAQ13-NP) FOR THE TREATMENT OF GLIOBLASTOMA. Neuro-Oncology. 26(Supplement_8). viii255–viii255.
3.
Müller, Antonia, Dullei Min, Gerlinde Wernig, et al.. (2019). Modeling Chronic Graft-versus-Host Disease in MHC-Matched Mouse Strains: Genetics, Graft Composition, and Tissue Targets. Biology of Blood and Marrow Transplantation. 25(12). 2338–2349. 14 indexed citations
4.
Xing, Yan, Michelle J. Smith, Christine Goetz, et al.. (2018). Thymic Epithelial Cell Support of Thymopoiesis Does Not Require Klotho. The Journal of Immunology. 201(11). 3320–3328. 4 indexed citations
5.
Garfin, Phillip M., et al.. (2014). Abstract B76: Manipulating tumor suppressors to improve thymus function following hematopoietic stem cell transplantation. Cancer Research. 74(20_Supplement). B76–B76. 1 indexed citations
6.
Garfin, Phillip M., Dullei Min, Jerrod L. Bryson, et al.. (2013). Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expression. The Journal of Experimental Medicine. 210(6). 1087–1097. 53 indexed citations
7.
Garfin, Phillip M., Patrick Viatour, Dullei Min, et al.. (2012). RB Controls Size, Cellularity, and T Cell Output of the Mouse Thymus. Blood. 120(21). 835–835.
8.
Chung, Brile, Dullei Min, Mark R. Krampf, et al.. (2010). Combined Effects of Interleukin-7 and Stem Cell Factor Administration on Lymphopoiesis after Murine Bone Marrow Transplantation. Biology of Blood and Marrow Transplantation. 17(1). 48–60. 15 indexed citations
9.
Chung, Brile, et al.. (2007). Prevention of graft-versus-host disease by anti–IL-7Rα antibody. Blood. 110(8). 2803–2810. 30 indexed citations
10.
Min, Dullei, Angela Panoskaltsis‐Mortari, Makoto Kuro‐o, et al.. (2006). Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood. 109(6). 2529–2537. 175 indexed citations
11.
Min, Dullei, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, et al.. (2002). Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood. 99(12). 4592–4600. 195 indexed citations
12.
Lim, Jaehyun, Jeong‐Kyu Park, Eun‐Kyeong Jo, et al.. (1999). Purification and Immunoreactivity of Three Components from the 30/32-Kilodalton Antigen 85 Complex inMycobacterium tuberculosis. Infection and Immunity. 67(11). 6187–6190. 42 indexed citations
13.
Kim, Hwa‐Jung, Eun‐Kyeong Jo, Jeong‐Kyu Park, et al.. (1999). Isolation and partial characterisation of the Triton X-100 solubilised protein antigen from Mycobacterium tuberculosis. Journal of Medical Microbiology. 48(6). 585–591. 9 indexed citations
14.
15.
Barone, Gary W., Donald E. Hricik, Christopher L. Marsh, et al.. (1996). Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.. PubMed. 28(4). 2183–6. 6 indexed citations
16.
Barone, Gary W., C. Martin Bunke, Miles G. Choc, et al.. (1996). Safety and tolerability of neoral vs sandimmune: 1-year data in primary renal allograft recipients. 28(4). 2183–2186. 5 indexed citations
17.
Wrenshall, Lucile E., A. J. Matas, D. M. Canafax, et al.. (1990). AN INCREASED INCIDENCE OF LATE ACUTE REJECTION EPISODES IN CADAVER RENAL ALLOGRAFT RECIPIENTS GIVEN AZATHIOPRINE, CYCLOSPORINE, AND PREDNISONE. Transplantation. 50(2). 233–236. 30 indexed citations
18.
Canafax, D. M., Dullei Min, Arthur J. Matas, et al.. (1990). Effects of initial cyclosporine dose and timing on long‐term creatinine levels in cadaver renal transplantation. Clinical Transplantation. 4(5pt2). 321–328. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhiro Mochizuki Breakdown of academic impact, for papers by Limin Xing Breakdown of academic impact, for papers by Indira Sahdev Breakdown of academic impact, for papers by Motoko Koyama Breakdown of academic impact, for papers by Kazutoshi Aoyama Breakdown of academic impact, for papers by Mohammed S. Chaudhry Breakdown of academic impact, for papers by Maria Giuseppina Cefalo Breakdown of academic impact, for papers by Jens Chemnitz Breakdown of academic impact, for papers by Rong‐Long Chen Breakdown of academic impact, for papers by Mohamed R. Daha
Rankless by CCL
2026